We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688188:SSEShanghai BOCHU Electronic Technology Corporation Limited Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥141.14

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai BOCHU Electronic Technology trades at CNY 141.14, sitting just above its 200‑day SMA of 141.3 but below the 20‑day (149.4) and 50‑day (151.3) averages, indicating a neutral technical stance. The stock is hovering near the calculated support of 136.7 with resistance around 158.5, while the MACD is bearish (line below signal) and the RSI at 41 suggests modest downside pressure but not oversold conditions. Volatility is elevated at 38.5% over the past 30 days and the beta is slightly negative (-0.18), implying limited correlation with the broader market but heightened price swings.
Fundamentally, BOCHU delivers impressive revenue growth of 32.6% and operating margins exceeding 50%, supported by a massive cash pile of over CNY 5.2 billion and negligible debt. However, its trailing PE of 38.6 sits above the industry average of 34.4, and the price‑to‑book of 6.78 signals a premium valuation. The dividend yield of 1.57% with a payout ratio near 56% appears sustainable given the strong balance sheet.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram and proximity to support level
  • High short‑term volatility
  • Attractive dividend yield but premium valuation

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and operating margins
  • Robust cash position and low leverage
  • Valuation still above peers despite earnings strength

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained high‑margin growth in industrial automation
  • Solid balance sheet with ample cash and modest debt
  • Dividend sustainability and potential sector tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth32.60%
Profit Margin50.49%
P/E Ratio38.6
ROE19.09%
Debt/Equity0.46
P/B Ratio6.8
Industry P/E34.4

Technical Analysis

TrendNeutral
RSI41.1
SupportCN¥136.71
ResistanceCN¥158.53
MA 20CN¥149.40
MA 50CN¥151.32
MA 200CN¥141.28
MACDBearish
VolumeIncreasing
Fear & Greed Index81.48

Valuation

GradeOvervalued
TypeGrowth
Dividend Yield1.57%

Risk Assessment

Beta-0.18
Volatility38.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.